Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[S,S]-Reboxetine in Postherpetic Neuralgia
NCT00354094Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of esreboxetine in postherpetic neuralgia (PHN), sponsored by Pfizer. Started Nov 2006; status: terminated.
02
Drugs
esreboxetine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00354094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354094.